Updated Jul 16, 2026
Kilroy Conor has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $143K.
Conor Kilroy is associated with Aura Biosciences, Inc., a biotechnology company focused on developing therapies for cancer treatment. Specific details about his role and contributions to the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | AURA | Aura Biosciences, Inc. | A — Grant or award | 14.9K | $0.00 | |
| 2026-04-16 | AURA | Aura Biosciences, Inc. | S — Open-market sale | 11.7K | $7.02 | $82K |
| 2026-03-03 | AURA | Aura Biosciences, Inc. | A — Grant or award | 62.3K | $0.00 | |
| 2026-02-18 | AURA | Aura Biosciences, Inc. | S — Open-market sale | 12.1K | $5.05 | $61K |
Conor Kilroy is associated with Aura Biosciences, Inc., a biotechnology company focused on developing therapies for cancer treatment. Specific details about his role and contributions to the company are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($143K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kilroy Conor profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.